Science regularly goes through cycles of fads that regularly embodies particular generations. In the 80s, it’s climate change and in the 90s, it was the internet. This time, it seems the gene-editing tool CRISPR is starting to steal the spotlight from other sectors in the scientific community and it’s not exactly hard to see why. It holds the potential to allow for major transformations on the genetic level.
As Futurism notes, CRISPR is basically causing a revolution within the scientific community, particularly in Biology. Being the single most powerful tool for manipulating organisms at a genetic level, it can be used to change the properties of absolutely anything. Little wonder why so many fear the method, with some imagining a future where people walk around with tails and horns.
In any case, CRISPR was awarded the 2015 Breakthrough of the Year award by Science magazine. It also found a cozy home on the pages of numerous prestigious publications, including the New Yorker and even entertainment media like The Hollywood Reporter are getting in on the game. There is even a TV series planned by NBC, which will feature CRISPR and have Jennifer Lopez as the lead.
The revolutionary technique is also starting to make its way outside of laboratories and to middle schools, NPR reports. There are numerous special sessions all over the country where students of all ages are introduced to the wondrous world of genetic manipulation.
This is made possible because, despite its highly effective nature in editing genes, CRISPR is also incredibly cheap. Students can get a kit for only $150 and with that, they can do things like creating a naturally spicy mango or a gerbil that changes colors.
What’s more, scientists are only beginning to scratch the full potential of the tool. In the coming years, biologists will be unleashing CRISPR on some of the world’s deadliest diseases, with some touching on the matter of immortality.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Neuralink Expands Brain Implant Trials with 12 Global Patients
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Lab-grown meat: you may find it icky, but it could drive forward medical research 



